Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations - PubMed (original) (raw)
. 1999 Nov 4;18(46):6271-7.
doi: 10.1038/sj.onc.1203033.
Affiliations
- PMID: 10597225
- DOI: 10.1038/sj.onc.1203033
Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations
M M Corcoran et al. Oncogene. 1999.
Abstract
The increased or inappropriate expression of genes with oncogenic properties through specific chromosome translocations is an important event in the pathogenesis of B-cell lymphoproliferative diseases. Recent studies have found deletions or translocations of chromosome 7q to be the most common cytogenetic abnormality observed in SLVL, a leukemic variant of SMZL, with the q21-q22 region being most frequently affected. In three patients with translocations between chromosomes 2 and 7, the cloning of the breakpoints at 7q21 revealed that each was located within a small region of DNA 3.6 kb upstream of the transcription start site of cyclin dependent kinase 6 (CDK6). In each case the translocation event was consistent with aberrant VJ recombination between the immunoglobulin light chain region (Ig kappa) on chromosome 2p12 and DNA sequences at 7q21, resembling the heptamer recombination site. The t(7;21) breakpoint in an additional patient with splenic marginal zone lymphoma (SMZL), resided 66 kb telomeric to the t(2;7) breakpoints juxtaposing CDK6 to an uncharacterized transcript. In two of the SLVL patient samples, the CDK6 protein was found to be markedly over expressed. These results suggest that dysregulation of CDK6 gene expression contributes to the pathogenesis of SLVL and SMZL.
Similar articles
- Sequencing of t(2;7) translocations reveals a consistent breakpoint linking CDK6 to the IGK locus in indolent B-cell neoplasia.
Parker EP, Siebert R, Oo TH, Schneider D, Hayette S, Wang C. Parker EP, et al. J Mol Diagn. 2013 Jan;15(1):101-9. doi: 10.1016/j.jmoldx.2012.07.006. Epub 2012 Nov 2. J Mol Diagn. 2013. PMID: 23127611 - Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.
Brito-Babapulle V, Gruszka-Westwood AM, Platt G, Andersen CL, Elnenaei MO, Matutes E, Wotherspoon AC, Weston-Smith SG, Catovsky D. Brito-Babapulle V, et al. Haematologica. 2002 Apr;87(4):357-62. Haematologica. 2002. PMID: 11940479 - Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
Parker E, Macdonald JR, Wang C. Parker E, et al. Cancer Genet. 2011 May;204(5):260-4. doi: 10.1016/j.cancergen.2011.03.004. Cancer Genet. 2011. PMID: 21665179 - Splenic lymphoma with villous lymphocytes showing del(7) and inv(10).
Wong KF, Chu YC, Hui PK. Wong KF, et al. Cancer Genet Cytogenet. 1998 Apr 15;102(2):145-7. doi: 10.1016/s0165-4608(97)00367-1. Cancer Genet Cytogenet. 1998. PMID: 9546069 Review. - Nodal and splenic marginal zone B cell lymphomas.
Mollejo M, Camacho FI, Algara P, Ruiz-Ballesteros E, García JF, Piris MA. Mollejo M, et al. Hematol Oncol. 2005 Sep-Dec;23(3-4):108-18. doi: 10.1002/hon.762. Hematol Oncol. 2005. PMID: 16307458 Review.
Cited by
- CDK4: a master regulator of the cell cycle and its role in cancer.
Baker SJ, Poulikakos PI, Irie HY, Parekh S, Reddy EP. Baker SJ, et al. Genes Cancer. 2022 Aug 25;13:21-45. doi: 10.18632/genesandcancer.221. eCollection 2022. Genes Cancer. 2022. PMID: 36051751 Free PMC article. Review. - Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M, Lotfi R, Yousefi AM, Bashash D. Zabihi M, et al. J Cancer Res Clin Oncol. 2023 Apr;149(4):1585-1606. doi: 10.1007/s00432-022-04135-6. Epub 2022 Jul 4. J Cancer Res Clin Oncol. 2023. PMID: 35781526 Review. - Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P, De Dominici M, Salvino J, Calabretta B. Porazzi P, et al. Genes (Basel). 2021 Aug 29;12(9):1355. doi: 10.3390/genes12091355. Genes (Basel). 2021. PMID: 34573335 Free PMC article. Review. - Diagnostic challenges in an aggressive case of peripheralizing marginal zone lymphoma.
Shah SI, D'Angelo CR, Kratz JD, Yang DT. Shah SI, et al. Clin Case Rep. 2020 Oct 18;8(12):3303-3310. doi: 10.1002/ccr3.3395. eCollection 2020 Dec. Clin Case Rep. 2020. PMID: 33363923 Free PMC article. - CDK6 Inhibition: A Novel Approach in AML Management.
Uras IZ, Sexl V, Kollmann K. Uras IZ, et al. Int J Mol Sci. 2020 Apr 5;21(7):2528. doi: 10.3390/ijms21072528. Int J Mol Sci. 2020. PMID: 32260549 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources